Effects of NMDAR Antagonist on the Regulation of P-MARCKS Protein to Aβ1-42 Oligomers Induced Neurotoxicity

Neurochemical Research
Yudong LiuGuozhao Ma

Abstract

Alzheimer's disease (AD) is a well-known neurodegenerative disease. Deposition of β-amyloid protein (Aβ) oligomers plays a crucial role in the disease progression. Previous studies showed that toxicity induced by Aβ oligomers in cultured neurons and adult rat brain was partially mediated by activation of glutamatergic N-methyl-D-aspartate receptors (NMDAR). Additionally, memantine, a noncompetitive NMDAR antagonist, can significantly improve cognitive functions in some AD patients. However, little is currently known about the potential role of NMDAR antagonist on the regulation of P-MARCKS protein to Aβ1-42 oligomers induced neurotoxicity. The protective effect and mechanism of NMDAR antagonist on primary neurons exposed to Aβ1-42 oligomers were investigated in the study. We have defined that the Aβ1-42 treatment decreased cell viability and increased apoptosis. Moreover, Aβ1-42 oligomers exposure increased P-MARCKS and PIP2 expressions, while decreased SYP expression. However, NMDAR antagonist pretreatment ameliorates Aβ1-42 oligomers induced neuronal apoptosis and partially reverses the expression of P-MARCKS, PIP2 and SYP. In conclusion, NMDAR antagonist may ameliorate neurotoxicity induced by Aβ1-42 oligomers through reduci...Continue Reading

References

Sep 16, 2004·Nature Reviews. Molecular Cell Biology·Paul A Janmey, Uno Lindberg
Oct 6, 2005·Neuron·Barbara Calabrese, Shelley Halpain
Jun 3, 2008·Experimental Brain Research·Revaz O SolomoniaGabriel Horn
Oct 27, 2009·Brain Research·Olga A TimofeevaEdward D Levin
Feb 21, 2013·Neuropathology and Applied Neurobiology·C GarwoodUNKNOWN MRC Cognitive Function and Ageing Neuropathology Study Group
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Niels R ReindersHelmut W Kessels
Dec 22, 2016·Journal of the American Chemical Society·Adam G KreutzerJames S Nowick
Dec 20, 2017·Journal of Alzheimer's Disease : JAD·Jaume FolchAntoni Camins

❮ Previous
Next ❯

Citations

Mar 9, 2021·Proteomics. Clinical Applications·Justin McKetneyJoshua J Coon

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
Assay

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.